1
From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global
Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Global Initiative for
Chronic Obstructive Lung Disease, Inc., 2011.
2Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. European Position
Paper on Rhinosinusitis and Nasal Polyps. Rhinol. 2012; 23: 1-298.
3
Brozek J, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB. Allergic
Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin
Immunol.2010; 126:466–476.
4.
Ragab S, Scadding GK, Lund VJ, Saleh AH, Khalifa MA. Treatment of chronic rhinosinusitis
and its effects on asthma. Eur Respir J.2006; 28:68-74.
5.
Roberts NJ, Lloyd-Owen SJ, Rapado F, Patel IS, Wilkinson TMA, Donaldson GC, et al.
Relationship between chronic nasal and respiratory symptoms in patients with COPD.
Respir Med.2003; 97:909-914.
6.
Hurst JR, Wilkinson TM, Donaldson GC, Wedzicha JA. Upper airway symptoms and quality
of life in chronic obstructive pulmonary disease (COPD). Respir Med.2004; 98:767-770.
7.Montnemery P, Svensson C, Adelroth E, Löfdahl CG, Andersson M, Greiff L, Persson CG.
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic
bronchitis/emphysema. Eur Respir J.2001; 17:596-603.
8.Piotrowska VM, Piotrowski WJ, Kurmanowska Z, Marczak J, Gorski P, Antczak A. Rhinosinusitis
in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids. Int J Chron
Obstruct Pulmon Dis.2010; 5:107-117.
9.
Sichletidis L, Tsiotsios I, Gavriilidis A, Chloros D, Kottakis I, Daskalopoulou E,
et al. Prevalence of chronic obstructive pulmonary disease and rhinitis in northern
Greece. Respiration.2005; 72:270-277.
10.Hakansson K, von Buchwald C, Thomsen SF, Thyssen JP, Backer V, Linneberg A. Nonallergic
rhinitis and its association with smoking and lower airway disease: a general population
study. Am J Rhinol Allergy.2011; 25: 25–29.
11.
Hurst JR, Kuchai R, Michael P, Perera WR, Wilkinson TM, Wedzicha JA. Nasal symptoms,
airway obstruction and disease severity in chronic obstructive pulmonary disease.
Clin Physiol Funct imaging.2006; 26:251-256.
12.Kelemence A, Abadoglu O, Gumus C, Berk S, Epozturk K, Akkurt I. The frequency of chronic
rhinosinusitis/nasal polyp in COPD and its effect on the severity of COPD. COPD.2011;
8:8-12.
13.
Dewan NA, Rafique S, Kanwar B, Satpathy H, Ryschon K, Tillotson GS, et al. Acute exacerbation
of COPD: factors associated with poor treatment outcome. Chest.2000; 117:662-671.
14.
Hurst JR. Upper airway. 3: Sinonasal involvement in chronic obstructive pulmonary
disease. Thorax.2010; 65:85-90.
15. Celakovsky P, Smatanova K, Kalfert D, Pracharova S, Koblizek V. Nasal symptomatology,
obstruction, and paranasal sinus opacity in patients with chronic obstructive pulmonary
disease. Acta Oto-Laryngologica. 2015; 135:598-601.
16.
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A. Standardisation
of spirometry. ERJ. 2005; 26:319-338.
17.
Recommendations for standardized procedures for the on-line and off-line measurement
of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999.
This official statement of the American Thoracic Society was adopted by the ATS Board
of Directors, July 1999. Am J Respir Crit Care Med. 1999; 160:2104-2117.
18.
Pepys J, Roth A, Carroll KB. RAST, skin and nasal tests and the history in grass pollen
allergy. Clin allergy.1975; 5:431-442.
19.
Baumann I, Blumenstock G, DeMaddalena H, Piccirillo JF, Plinkert PK. Quality of life
in patients with chronic rhinosinusitis: validation of the Sino-Nasal Outcome Test-20
German Adapted Version. HNO. 2007; 55:42-47.
20.
Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version
of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allerg Clin Immunol. 1999;
104:364-369.
21.
Ashraf N, Bhattacharyya N. Determination of the “incidental” Lund score for the staging
of chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2001; 125(5):483-6.
22.
Hurst JR, Wilkinson TM, Perera WR, Donaldson GC, Wedzicha JA. Relationships among
bacteria, upper airway, lower airway, and systemic inflammation in COPD. CHEST. 2005;
127:1219-1226.
23.
Tschopp JM, Sistek D, Schindler C, Leuenberger P, Perruchoud AP, Wüthrich B. Current
allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic
markers (IgE, skin prick tests, and Phadiatop). Results from 8329 randomized adults
from the SAPALDIA Study. Swiss Study on Air Pollution and Lung Diseases in Adults.
Allergy. 1998; 53:608-613.
24. Neves MC, Neves YC, Mendes CM, Bastos MN, Camelier AA, Queiroz CF, et al.
Evaluation of atopy in patients with COPD. Journal brasileiro de pneumologia. 2013;
39:296-305.
25.
Canova CR, Downs SH, Knoblauch A, Andersson M, Tamm M, Leuppi JD. Increased prevalence
of perennial allergic rhinitis in patients with obstructive sleep apnea. Respiration.
2004; 71:138-143.